Novartis Continues Alzheimer's Drug Litigation, Consolidates Suits For Discovery
Two separate patent infringement lawsuits brought by Swiss drug maker Novartis against Sun Pharmaceuticals over the Alzheimer drug Exelon have been consolidated in a New York federal court....To view the full article, register now.
Already a subscriber? Click here to view full article